122 related articles for article (PubMed ID: 28856784)
1. Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure.
Shemer A; Gupta AK; Kamshov A; Babaev M; Farhi R; Daniel CR; Foley KA
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28856784
[TBL] [Abstract][Full Text] [Related]
2. Onychomycosis.
Zaraa I; Dehavay F; Richert B
Hand Surg Rehabil; 2024 Apr; 43S():101638. PubMed ID: 38218374
[TBL] [Abstract][Full Text] [Related]
3. Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis-Results of an in vitro investigation.
Schaller M; Walker B; Nabhani S; Odon A; Riel S; Jäckel A
Mycoses; 2024 Mar; 67(3):e13710. PubMed ID: 38414346
[TBL] [Abstract][Full Text] [Related]
4. Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents.
Gupta AK; Elewski B; Joseph WS; Lipner SR; Daniel CR; Tosti A; Guenin E; Ghannoum M
Mycoses; 2024 Jan; 67(1):e13683. PubMed ID: 38214375
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical trichloroacetic acid 100% either alone or combined with topical tioconazole 28% versus systemic itraconazole in the treatment of onychomycosis.
Ibrahim AM; Ibrahim NS; Elgharabawy ES; Morsi HM
Mycoses; 2024 Jan; 67(1):e13690. PubMed ID: 38214347
[TBL] [Abstract][Full Text] [Related]
6. Outcome of fosravuconazole treatment for onychomycosis refractory to topical antifungal agents.
Inoue T; Watabe D; Tsunemi Y; Amano H
J Dermatol; 2023 Aug; 50(8):1014-1019. PubMed ID: 37157898
[TBL] [Abstract][Full Text] [Related]
7. Updated Perspectives on the Diagnosis and Management of Onychomycosis.
Falotico JM; Lipner SR
Clin Cosmet Investig Dermatol; 2022; 15():1933-1957. PubMed ID: 36133401
[TBL] [Abstract][Full Text] [Related]
8. Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics.
Tsunemi Y; Otsuka A; Nonaka Y
J Dermatol; 2024 Apr; 51(4):526-531. PubMed ID: 38279193
[TBL] [Abstract][Full Text] [Related]
9. Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics.
Yousefian F; Smythe C; Han H; Elewski BE; Nestor M
J Clin Aesthet Dermatol; 2024 Mar; 17(3):24-33. PubMed ID: 38495549
[TBL] [Abstract][Full Text] [Related]
10. Cure Rates of Control Interventions in Randomized Trials for Onychomycosis Treatments: A Systematic Review and Meta-Analysis.
Gupta AK; Venkataraman M; Quinlan EM; Bamimore MA
J Am Podiatr Med Assoc; 2021 Jun; ():. PubMed ID: 34121113
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Onychomycosis: Perspectives from a Joint Podiatry-Dermatology Roundtable.
Markinson BC; Vlahovic TC; Joseph WS; Scher RK; Tosti A; Plasencia J; Pariser DM
J Am Podiatr Med Assoc; 2015 Sep; ():. PubMed ID: 26406281
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women.
Kaul S; Yadav S; Dogra S
Indian Dermatol Online J; 2017; 8(5):310-318. PubMed ID: 28979861
[TBL] [Abstract][Full Text] [Related]
13. New formulation for topical treatment of onychomycoses.
Difonzo EM; Scarfì F; Galeone M
G Ital Dermatol Venereol; 2017 Oct; 152(5):432-435. PubMed ID: 28906086
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
Schaller M; Sigurgeirsson B; Sarkany M
Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
[TBL] [Abstract][Full Text] [Related]
15. Laser-assisted Photodynamic Therapy or Laser-assisted Amorolfine Lacquer Delivery for Treatment of Toenail Onychomycosis: An Open-label Comparative Study.
Koren A; Salameh F; Sprecher E; Artzi O
Acta Derm Venereol; 2018 Apr; 98(4):467-468. PubMed ID: 29265166
[No Abstract] [Full Text] [Related]
16. Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.
Gupta AK; Versteeg SG; Shear NH
J Cutan Med Surg; 2018; 22(2):129-141. PubMed ID: 28954534
[TBL] [Abstract][Full Text] [Related]
17. Management of mycoses in daily practice.
Drago L; Micali G; Papini M; Piraccini BM; Veraldi S
G Ital Dermatol Venereol; 2017 Dec; 152(6):642-650. PubMed ID: 29050446
[TBL] [Abstract][Full Text] [Related]
18. A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis.
Parekh M; Ramaiah G; Pashilkar P; Ramanujam R; Johnston P; Ilag LL
BMC Complement Altern Med; 2017 Sep; 17(1):464. PubMed ID: 28923039
[TBL] [Abstract][Full Text] [Related]
19. Oral Medications to Treat Toenail Fungal Infection.
Kreijkamp-Kaspers S; Hawke KL; van Driel ML
JAMA; 2018 Jan; 319(4):397-398. PubMed ID: 29362778
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial designs for topical antifungal treatments of onychomycosis and implications on clinical practice.
Rich P; Vlahovic TC; Joseph WS; Zane LT; Hall SB; Gellings Lowe N; Adigun CG
Cutis; 2017 Oct; 100(4):259-264. PubMed ID: 29136060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
